Avondale Partners Starts DexCom (DXCM) at Market Outperform
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $73.71 -3.46%
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 22 | New: 8
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 22 | New: 8
Join SI Premium – FREE
Avondale Partners initiates coverage on DexCom (NASDAQ: DXCM) with a Market Outperform. PT $12.50.
For an analyst ratings summary and ratings history on DexCom click here. For more ratings news on DexCom click here.
Shares of DexCom closed at $9.64 yesterday.
For an analyst ratings summary and ratings history on DexCom click here. For more ratings news on DexCom click here.
Shares of DexCom closed at $9.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Health Canada authorizes Dexcom G7 15 Day CGM for Canadian adults
- Bernstein SocGen Group Starts Asymchem Laboratories Tianjin Co Ltd (002821:CH) at Outperform
- Maxim Group Starts Heartbeam Inc. (BEAT) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Avondale PartnersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
